Bis(pyrazole)- and bis(pyrazolyl)-palladium complexes as phenylacetylene polymerization catalysts

Two types of pyrazole-based palladium complexes were used to catalyze the polymerization of phenylacetylene. Catalysts with electron-withdrawing linkers, [{1,3-(3,5-R₂pzCO)₂C₆H₄}Pd₂Cl₂(μ-Cl)₂] (R = ^tBu (1), Ph (2), Me (3), [{2,6-(3,5-R₂pzCO)₂C₅H₃N)}PdCl₂] (R = ^tBu (4), Me (5)), show high conversion; whilst those with simple pyrazole ligands, [(3,5-R₂pz)₂PdCl₂] (R = H (6), Me (7), ^tBu (8)), [(3,5-^tBu₂pz)₂PdCl(Me)] (9), have much lower conversions. Conversion greatly improved when 9 was used to catalyze the co-polymerization of sulfur dioxide and phenylacetylene. Both types of catalysts produce predominantly trans–cisoidal polyphenylacetylene.     

Synthesis and characterization of some trans-hydridomethylbis(phosphine)-platinum(II) and -palladium(II) complexes

Several trans-hydridomethylbis(phosphine)-platinum(II) and -palladium(II) complexes have been made by the reaction: trans-M(H)Cl(PR₃)₂ + CH₃MgBr → trans-M(CH₃)(PR₃)₂ + MgClBr and their structures determined by ¹H NMR and IR spectroscopy. The complexes in which M  Pt and R  Cy (cyclohexyl) or i-Pr (isopropyl) are very stable in the solid state and in solution, while the compounds in which M  Pt, R  Et (ethyl) and M  Pd, R  i-Pr slowly decompose either in the solid state or in solution. The compound in which M  Pd and R  Cy was not isolated but was identified in solution.     

New palladium(II) complexes with pyrazole ligands

The pyrazole ligand 3,5-dimethyl-4-iodopyrazole (HdmIPz) has been used to obtain a series of palladium(II) complexes (1–4) of the type [PdX₂(HdmIPz)₂] {X = Cl⁻ (1); Br⁻ (2); I⁻ (3); SCN⁻ (4)}. All compounds have been isolated, purified, and characterized by means of elemental analysis, IR spectroscopy, ¹H and ¹³C{¹H}-NMR experiments, differential thermal analysis (DTA), and thermogravimetry (TG). The TG/DTA curves showed that the compounds released ligands in the temperature range 137–605 °C, yielding metallic palladium as final residue. The complexes and the ligand together with cisplatin have been tested in vitro by MTT assay for their cytotoxicity against two murine cancer cell lines: mammary adenocarcinoma (LM3) and lung adenocarcinoma (LP07).     

New palladium(II) complexes with pyrazole ligands

This study describes the synthesis, IR, ¹H, and ¹³C{¹H} NMR spectroscopic as well the thermal characterization of the new palladium(II) pyrazolyl complexes [PdCl₂(HmPz)₂] 1, [PdBr₂(HmPz)₂] 2, [PdI₂(HmPz)₂] 3, [Pd(SCN)₂(HmPz)₂] 4 {HmPz = 4-methylpyrazole}. The residues of the thermal decomposition were identified as Pd⁰ by X-ray powder diffraction. From the initial decomposition temperatures, the thermal stability of the complexes can be ordered in the sequence: 1 > 2 > 4 ≈ 3. The cytotoxic activities of the complexes and the ligand were investigated against two murine cancer cell lines: mammary adenocarcinoma (LM3) and lung adenocarcinoma (LP07) and compared to cisplatin under the same experimental conditions.     

Synthesis and structure of highly substituted pyrazole ligands and their complexes with platinum(II) and palladium(II) metal ions

Reaction of 3-methoxycarbonyl-2-methyl- or 3-dimethoxyphosphoryl-2-methyl-substituted 4-oxo-4H-chromones 1 with N-methylhydrazine resulted in the formation of isomeric, highly substituted pyrazoles 4 (major products) and 5 (minor products). Intramolecular transesterification of 4 and 5 under basic conditions led, respectively, to tricyclic derivatives 7 and 8. The structures of pyrazoles 4a (dimethyl 2-methyl-4-oxo-4H-chromen-3-yl-phosphonate) and 4b (methyl 4-oxo-2-methyl-4H-chromene-3-carboxylate) were confirmed by X-ray crystallography. Pyrazoles 4a and 4b were used as ligands (L) in the formation of ML₂Cl₂ complexes with platinum(II) or palladium(II) metal ions (M). Potassium tetrachloroplatinate(II), used as the metal ion reagent, gave both trans-[Pt(4a)₂Cl₂] and cis-[Pt(4a)₂Cl₂], complexes with ligand 4a, and only cis-[Pt(4b)₂Cl₂] isomer with ligand 4b. Palladium complexes were obtained by the reaction of bis(benzonitrile)dichloropalladium(II) with the test ligands. trans-[Pd(4a)₂Cl₂] and trans-[Pd(4b)₂Cl₂] were the exclusive products of these reactions. The structures of all the complexes were confirmed by IR, ¹H NMR and FAB MS spectral analysis, elemental analysis and Kurnakov tests.     

Synthesis,characterization, and antitumor activities of two copper(II) complexes with pyrazole derivatives

Two mononuclear copper(II) complexes with pyrazole derivatives, 1,1′-(anthracen-9-ylmethylene)bis(1H-pyrazole) (L¹ ) and 9-(4-(di(1H-pyrazol-1-yl)methyl)phenyl)-9H-carbazole (L² ), of formulae [CuL¹(CH₃CN)₂](ClO₄)₂ (1) and [CuL²(CH₃CN)₂](ClO₄)₂ (2) were prepared. Both complexes were confirmed by IR, MS, ¹H NMR, and elemental analyses. Complex 1 was also characterized by X-ray crystallography, confirming that copper(II) is coordinated by four nitrogen atoms from two L¹ and two oxygen atoms from two perchlorates. Furthermore, all ligands and complexes were tested in vitro for their antitumor activities using mouse melanoma cell line B16-F10, HepG2 human hepatoma cell line, and A549 human lung adenocarcinoma cell line. Both complexes displayed potent cytotoxicity and are promising substrates for further investigations.     

Seven-coordinate complexes of molybdenum(II) and tungsten(II) containing pyrazole as a ligand

Summary Equimolar quantities of [MI₂(CO)₃(NCMe)₂] (M = Mo or W) and C₃H₄N² (pyrazole) react in CH₂C1₂ at room temperature to give the iodo-bridged dimers [M(μ-I) (CO)₃(C₃H₄N²)]₂ (1) and (2). Two equivalents of C₃H₄N² react with [MI₂(CO)₃(NCMe)₂] (M = Mo or W) to give the bis(pyrazole) complexes [MI₂(CO)₃(C₃H₄N²)₂] (3) and (4) in good yield. Three and four equivalents of pyrazole react with [MoI₂(CO)₃(NCMe)₂] to give the cationic complexes [MoI(CO)₃(C₃H₄N²)₃]I (5) and [MoI(CO)₂(C₃H₄N²)₄]I (6), respectively. The mixed ligand complexes [MI₂(CO)₃(C₃H₄N²)L] (M = Mo or W; L = PPh₃, AsPh₃ or SbPh₃) (7)-(12) are prepared by reacting equimolar amounts of [MI₂(CO)₃(NCMe)₂] and L in CH₂C1₂ at room temperature, followed by an in situ reaction with one equivalent of C₃H₄N². The MoSnCl₃ complex [MoCl(SnCl₃)(CO)₃(C₃H₄N²)₂] (13) is prepared in an analogous manner using acetone as the solvent, whilst the mixed ligand compound [MoCl(SnQ₃)(CO) ₃(C₃H₄N²)(PPh₃)] (14) was prepared by treating the dimeric complex [Mo(μ-Cl)(SnCl₃)(CO)₃(PPh₃)]₂ with two equivalents of C₃H₄N². All the new complexes were characterised by elemental analysis (carbon, hydrogen and nitrogen), i.r. and ¹H n.m.r. spectroscopy.     

Physico-chemical and thermal characterisation of new Co(II) complexes with pyrazole derivatives

Four new complexes having general formula [CoL₂(acr)₂] (L: 1H-pyrazole (Hpz) (1); 3-methyl-1H-pyrazole (3-Me-Hpz) (2); 4-methyl-1H-pyrazole (4-Me-Hpz) (3); 3,5-dimethyl-1H-pyrazole (Hdmpz) (4); acr: acrylato ion) were synthesised and characterised. The infrared and UV–vis spectral data indicate that these pyrazole derivatives act as unidentate while acrylato ions act as bidentate chelate ligands generating Co(II) complexes with octahedral stereochemistry. TG experiments revealed the nature of complex species as anhydrous and confirmed those compositions. The biological assays revealed a good activity against Bacillus subtilis for all complexes.     

Crystal structures of copper(II) and zinc(II) complexes derived from 3-(2-pyridyl)pyrazole

Two dinuclear complexes [Zn(μ-L)(NO₃)(H₂O)]₂ (1) and [Cu₂(μ-L)₂(HL)₂](NO₃)₂(C₁₂H₈Br₂)_0.5·H₂O (2), (HL = 3-(2-pyridyl)pyrazole, C₁₂H₈Br₂ = 4,4′-dibromobiphenyl) are synthesized under hydrothermal conditions and characterized by elemental analysis and X-ray single crystal diffraction. Crystal data for 1: triclinic, \(P\bar 1\), a = 8.8478(7) Å, b = 15.0550(11) Å, c = 16.4310(12) Å, α = 107.588(4)°, β = 112.498(3)°, γ = 115.595(3)°, V = 2099.8(9) ų, Z = 2; for 2: triclinic, \(P\bar 1\), a = 7.2870(15) Å, b = 8.6840(17) Å, c = 9.3290(19) Å, α = 107.588(4)°, β = 112.498(3)°, γ = 115.595(3)°, V = 528.77(18) ų, Z = 1. Complex 1 and 2 are both dinuclear structures which are further packed into a 1D supramolecular chain and a 3D supramolecular framework via weak C–H…O hydrogen bond interactions respectively.     

Synthesis of copper(II) and nickel(II) triazacycloalkane complexes

Summary Copper(II) and nickel(II) complexes of triazacycloalkanes (pqr-cy), with p, q, r = 2–6, have been prepared and characterized by means of electronic and i.r. spectroscopy, and by magnetic measurements. With nickel(II) mononuclear octahedral complexes [Ni(pgr-cy)₂](CI0₄)₂ are formed, but for copper(II) mononuclear octahedral complexes were obtained only for 222-cy and 223-cy. The other ligands gave copper(II) complexes of the type [Cu(pgr-cy)CI]CIO₄, [Cu(pgr-cy)OH]ClO₄, Or [Cu(pgr-cy)CI_1/2OH_1/2]ClO₄. The hydroxy complexes have low magnetic moments and binuclear hydroxy bridged structures are proposed.Ligand names: e.g. p = q = r = 2 is 1,4,7-triazacvclononane     

Dioxouranium(VI) complexes ofN-(orthovanillidene)-anthranilic acid andN-(vanillidene)-anthranilic acid

Summary Two structurally related reagents,N-(orthovanillidene)-anthranilic acid (H₂L¹) andN-(vanillidene)anthranilic acid (H₂L²), have been used to synthesize new uranyl complexes having different metal-ligand ratios, e.g. 11, 23 and 12 using various starting materials. The products have been isolated in the solid state and characterized by elemental analyses, molar conductances in methanol, t.g.a., electronic, i.r., and¹H n.m.r. spectral data.     

Crystallographic and spectroscopic studies on palladium(II) complexes containing pyrazole and thiocyanate ligands

Mononuclear palladium(II) complexes containing both pyrazole-type ligands and thiocyanate, of general formula [Pd(SCN)₂(L)₂] {L = pyrazole (HPz) and 1-phenyl-3-methylpyrazole (phmPz)} have been prepared and characterized by elemental analysis, i.r. and n.m.r. spectroscopy and by single crystal X-ray diffraction methods. The Pd atom in these structures lies on the crystallographic inversion center; in a square-planar coordination geometry made by two sulfur and two nitrogen atoms of the ligands, both in trans positions.     

Synthesis of palladium(II) and nickel(II) complexes with tetrabenzoporphine

Palladium and nickel complexes with tetrabenzoporphine were synthesized by reacting tetrabenzoporphine and cadmium tetrabensoporphine with palladium and nickel chlorides in boiling dimethylformamide and identified.     

X-ray structural and spectroscopic investigation of cyanamidonitrate nickel(II) complexes with pyrazole type ligands

New cyanamidonitrate complexes of the type [Ni(NO₂NCN)₂L₄], where L = pyrazole (pz), 3(5)-methylpyrazole (mpz), 3,5-dimethylpyrazole (dmpz), 3,4,5-trimethylpyrazole (tmpz), indazole (benzopyrazole; inz), 4-bromopyrazole (Br-pz) and 4-iodopyrazole (I-pz) have been isolated and characterized by i.r. and electronic spectroscopy. The crystal structure of [Ni(NO₂NCN)₂(pz)₄] was solved by X-ray crystallography. The Ni^II environment is practically octahedral, composed of four tertiary nitrogens from pyrazole ligands and two nitrile nitrogens from cyanamidonitrate groups. According to the spectral results similar molecular structures can be attributed to all remaining complexes. The i.r. spectra exhibit changes in the cyanamidonitrate vibrations caused by coordination of this group. The electronic spectra are in agreement with the practically octahedral Ni^II environment.     

Synthesis,crystal, molecular and electronic structures of thiocyanate ruthenium(II) complexes with pyrazole,benzimidazole and triazole ligands

The [Ru(SCN)₂(PPh₃)₂(L)₂] complexes, where L = HPz, PhIm, HTz, have been prepared and studied by IR, NMR, UV–vis spectroscopy and X-ray crystallography. The complexes were prepared in the reactions of [RuCl₂(PPh₃)₃] with pyrazole, benzimidazole and triazole in methanol solutions. The electronic structures of the obtained compounds have been calculated using the TD–DFT method.